New Releases from NCBI BookshelfEtrasimod (Velsipity): Indication: For the treatment of adults with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy or an advanced treatment: CADTH Reimbursement Recommendation [Internet].​Etrasimod (Velsipity): Indication: For the treatment of adults with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy or an advanced treatment: CADTH Reimbursement Recommendation [Internet].